Table 2. Relationship between Caspase-2 expression and clinical pathological factors in glioma cancer.
| Variable | Patients | negative | positive | p value |
|---|---|---|---|---|
| Gender | ||||
| Male | 50 | 36 (72.0%) | 14 (28.0%) | 0.8042 a |
| Female | 32 | 24 (75.0%) | 8 (25.0%) | |
| Age | ||||
| < = 40 | 36 | 24 (66.7%) | 12 (33.3%) | 0.3160 a |
| > 40 | 46 | 36 (78.3%) | 10 (21.7%) | |
| Pathological stage | ||||
| normal | 10 | 7 (70%) | 3 (30.3%) | 1.0000 a |
| tumor | 72 | 53 (73.6%) | 19 (26.4%) | |
| 1 | 7 | 7 (100%) | 0 (0.0%) | 0.0024 b |
| 11 | 47 | 37 (78.7%) | 10 (21.3%) | |
| III | 9 | 6 (66.7%) | 3 (33.3%) | |
| IV | 9 | 3 (33.3%) | 6 (66.7%) | |
a
Two-sided Fisher's Exact Test.
b
Mann-Whitney U Test.